Iron homeostasis in host defence and inflammation
Open accessAbstract
Iron is an essential trace element for multicellular organisms and nearly all microorganisms. Although iron is abundant in the environment, common forms of iron are minimally soluble and therefore poorly accessible to biological organisms. Microorganisms entering a mammalian host face multiple mechanisms that further restrict their ability to obtain iron and thereby limit their pathogenicity. Iron levels also modulate host defence, as iron content in macrophages regulates their cytokine production. Here, we review recent advances that highlight the role of systemic and cellular iron-regulating mechanisms in protecting hosts from infection, emphasizing aspects that are applicable to human health and disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 88 cited sources checked · 0 supported · 0 flagged
- Interpretationreasoning
Hepcidin-induced hypoferraemia limits the availability of non-transferrin-bound iron during infections.
“Therefore, we propose that hepcidin-induced hypoferraemia functions to limit the availability of non-transferrin-bound iron during infections.”
Quote in the paperNot a substantial claim - Interpretationreasoning
The hypoferraemic response evolved to increase transferrin's capacity to bind iron released during acute infection and tissue destruction, thereby limiting non-transferrin-bound iron available to microorganisms.
“We propose that the hypoferraemic response evolved to provide an increased capacity for transferrin to bind iron that would be released during acute infection and during the associated destruction of tissues and erythrocytes, and so limit the generation of non-transferrin-bound iron that can be readily used by many microorganisms.”
Quote in the paperSubstantial claim- Rests on an assumption: Most microorganisms depend absolutely on exogenous iron for survival.
- Rests on an assumption: Malarial parasites require iron at both the liver and erythrocyte stages.
- Interpretationreasoning
This mechanism is particularly effective against bacterial strains that lack siderophore-mediated iron uptake, such as marine Vibrio species.
“This mechanism is particularly effective against bacterial strains that lack siderophore-mediated iron uptake (for example, marine Vibrio species).”
Quote in the paperNot a substantial claim - Premisecitation
Treatment with hepcidin agonists (minihepcidins) rescues mice infected with siderophilic bacteria by inducing hypoferraemia and redistributing iron from extracellular space into macrophages.
“Interestingly, mice infected with siderophilic bacteria were rescued by treatment with potent hepcidin agonists (known as minihepcidins) that induced hypoferraemia. These treatments had little or no effect on iron stores but redistributed iron from the extracellular space into macrophages.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015). This study shows that hepcidin-deficient mice are rapidly killed by V. vulnificus , but mice can be saved by the administration of minihepcidin, demonstrating the protective effect of hypoferraemia. source
Not checked in the free run.
- Premisecitation
Iron-targeted nutritional immunity consists of constitutive and inducible mechanisms that deny iron to invading pathogens and thereby limit their harm to the host.
“This led to the concept of iron-targeted nutritional immunity as a set of constitutive and inducible mechanisms that deny iron to invading pathogens and thereby limit their ability to harm the host1.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [1] Weinberg, E. D. Nutritional immunity: host's attempt to withhold iron from microbial invaders. JAMA 231, 39–41 (1975). source
Not checked in the free run.
- Premisecitation
Hepcidin-deficient mice die of sepsis within 16 hours after subcutaneous infection with V. vulnificus at doses tolerated by wild-type mice.
“Hepcidin-deficient mice die of sepsis in less than 16 hours after subcutaneous infection with V. vulnificus at doses that are otherwise well tolerated by wild-type mice52.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015). This study shows that hepcidin-deficient mice are rapidly killed by V. vulnificus , but mice can be saved by the administration of minihepcidin, demonstrating the protective effect of hypoferraemia. source
Not checked in the free run.
- Premisecitation
Hepcidin-deficient mice are more susceptible than wild-type mice to death from infection with Y. enterocolitica and certain attenuated strains of Y. pestis.
“Hepcidin-deficient mice are also much more susceptible than wild-type mice to death from infection with Y. enterocolitica (D. Stefanova, Y. Bulut, T.G. and E.N., unpublished observations) and certain attenuated strains of Y. pestis47.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [47] Quenee, L. E. et al. Hereditary hemochromatosis restores the virulence of plague vaccine strains. J. Infect. Dis. 206, 1050–1058 (2012). source
Not checked in the free run.
- Premisecitation
Ex vivo growth of V. vulnificus in mouse sera is greatly accelerated by adding ferric iron in amounts exceeding transferrin's binding capacity.
“Ex vivo growth of V. vulnificus in mouse sera was greatly accelerated by the addition of ferric iron in amounts that exceeded the binding capacity of transferrin52.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015). This study shows that hepcidin-deficient mice are rapidly killed by V. vulnificus , but mice can be saved by the administration of minihepcidin, demonstrating the protective effect of hypoferraemia. source
Not checked in the free run.
- Premisereasoning
High hepcidin concentrations cause iron sequestration in macrophages, redistributing iron from plasma and from non-macrophage storage in hepatocytes.
“High hepcidin concentrations cause iron sequestration in macrophages, which effectively redistributes iron not only from the plasma compartment but also from non-macrophage storage in hepatocytes.”
Quote in the paperSubstantial claim - Premisecitation
Indiscriminate iron supplementation may increase morbidity and mortality from malaria, diarrhoeal illness and tuberculosis.
“Unfortunately, evidence is accumulating that indiscriminate iron supplementation may increase morbidity and mortality from malaria, diarrhoeal illness and tuberculosis57–59.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [57] Murray, M. J., Murray, A. B., Murray, M. B. & Murray, C. J. The adverse effect of iron repletion on the course of certain infections. Br. Med. J. 2, 1113–1115 (1978). source
Not checked in the free run.
- cites [58] Oppenheimer, S. J. Iron and its relation to immunity and infectious disease. J. Nutr. 131, 616S–635S (2001). source
Not checked in the free run.
- cites [59] Sazawal, S. et al. Effects of routine prophylactic supplementation with iron and folic acid on admission to hospital and mortality in preschool children in a high malaria transmission setting: community-based, randomised, placebo-controlled trial. Lancet 367, 133–143 (2006). source
Not checked in the free run.
- Premisecitation
Macrophage iron depletion, seen in iron deficiency and paradoxically in hereditary haemochromatosis, may have pro-inflammatory effects.
“There is increasing evidence from mouse models that the macrophage iron depletion seen in iron deficiency, and paradoxically also in hereditary haemochromatosis, may have pro-inflammatory effects67.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [67] Pagani, A. et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 118, 736–746 (2011). source
Not checked in the free run.
- Premisecitation
In untransfused patients with β-thalassaemia, blood hepcidin levels are very low despite high iron concentrations and iron deposition, due to suppression by mediators from expanded erythroblasts.
“Despite high concentrations of iron and deposition of iron in the liver and other vital organs, the blood level of hepcidin in untransfused patients with β-thalassaemia is very low38–40, owing to suppression by mediators originating from the expanded erythroblast population in the bone marrow12,41.”
Quote in the paperSubstantial claim0 of 5 sources checked- cites [38] Kearney, S. L. et al. Urinary hepcidin in congenital chronic anemias. Pediatr. Blood Cancer 48, 57–63 (2007). source
Not checked in the free run.
- cites [39] Origa, R. et al. Liver iron concentrations and urinary hepcidin in β-thalassemia. Haematologica 92, 583–588 (2007). source
Not checked in the free run.
- cites [40] Jones, E. et al. Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait. Blood 125, 873–880 (2015). source
Not checked in the free run.
- cites [12] Kautz, L. et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet. 46, 678–684 (2014). source
Not checked in the free run.
- cites [41] Tanno, T., Noel, P. & Miller, J. L. Growth differentiation factor 15 in erythroid health and disease. Curr. Opin. Hematol. 17, 184–190 (2010).
Not checked in the free run.
- Premisecitation
IL-6 is the main cytokine that stimulates hepcidin synthesis during infection and inflammation.
“Interleukin-6 (IL-6) is the main cytokine that stimulates hepcidin synthesis during infection19 and inflammation, but other factors can also contribute, including activin B20, type I interferons (IFNs)21,22 and BMP2 (REF. 23).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [19] Nemeth, E. et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J. Clin. Invest. 113, 1271–1276 (2004). In this paper, the authors present evidence of the key role of IL-6 in the induction of hepcidin expression and the resulting hypoferraemia. source
Not checked in the free run.
- Premisecitation
Hereditary haemochromatosis is characterized by partial or complete hepcidin deficiency caused by genetic lesions in regulators of HAMP transcription or in HAMP itself.
“Hereditary haemochromatosis is a disease characterized by partial or complete hepcidin deficiency that is caused by genetic lesions in the regulators of HAMP transcription or in the HAMP gene itself33.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [33] Camaschella, C. & Poggiali, E. Inherited disorders of iron metabolism. Curr. Opin. Pediatr. 23, 14–20 (2011). source
Not checked in the free run.
- Premisecitation
Transferrin saturation levels greater than 80% are prominently associated with the formation of non-transferrin-bound iron, which is rapidly taken up by vulnerable tissues through alternative iron transporters.
“Transferrin saturation levels of greater than 80% are prominently associated with the formation of non-transferrin-bound iron, which is then rapidly taken up by vulnerable tissues (such as hepatocytes and cardiac myocytes) through alternative iron transporters (such as zinc transporter ZIP14 (also known as SLC39A14) in the liver34).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] Pinilla-Tenas, J. J. et al. Zip14 is a complex broad-scope metal-ion transporter whose functional properties support roles in the cellular uptake of zinc and nontransferrin-bound iron. Am. J. Physiol. Cell Physiol. 301, C862–C871 (2011). source
Not checked in the free run.
- Premisecitation
The increase in hepcidin secretion in response to infectious or inflammatory stimuli is responsible for the characteristic hypoferraemia of inflammation.
“The increase in hepcidin secretion in response to infectious or inflammatory stimuli is responsible for the characteristic hypoferraemia of inflammation26,27, which develops within a few hours of a systemic infection or following injection of microbial components or certain cytokines.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [26] Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037–1044 (2002). source
Not checked in the free run.
- cites [27] Goodnough, L. T., Nemeth, E. & Ganz, T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116, 4754–4761 (2010). source
Not checked in the free run.
- Premisecitation
The local and systemic responses to aseptic inflammation in vivo are preserved in mice lacking either IREBP1 or IREBP2.
“However, the local and systemic responses to aseptic inflammation in vivo are preserved in the absence of either of the two IREBPs3, which suggests that the role of the IREBPs in host defence and inflammation is minor or that the two IREBPs have mostly overlapping functions, an issue that needs to be examined further.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Viatte, L., Grone, H. J., Hentze, M. W. & Galy, B. In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation. J. Mol. Med. 87, 913–921 (2009). source
Not checked in the free run.
- Premisecitation
Pathogenicity of Y. pestis strains lacking yersiniabactin is greatly enhanced in haemochromatotic mice generated by disruption of hepcidin or haemojuvelin.
“The pathogenicity of similar strains was greatly enhanced in haemochromatotic mice that were generated by disruption of the gene encoding either hepcidin or its essential regulator haemojuvelin47.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47] Quenee, L. E. et al. Hereditary hemochromatosis restores the virulence of plague vaccine strains. J. Infect. Dis. 206, 1050–1058 (2012). source
Not checked in the free run.
- Premisenone given
In mice, BMP6 is required for normal hepcidin production and iron regulation in vivo.
“In mice, BMP6 is the BMPR ligand that is required for normal hepcidin production and iron regulation in vivo, but other BMPs also have stimulatory activity in this system.”
Quote in the paperSubstantial claim - Premisecitation
Patients with hereditary haemochromatosis are predisposed to otherwise rare infections with V. vulnificus and related Vibrio species, and with Y. enterocolitica.
“Although the relative risk has not yet been estimated, it is clear that patients with hereditary haemochromatosis are predisposed to otherwise rare infections with two Gram-negative bacterial species: the marine organism Vibrio vulnificus42 (and related Vibrio species) and the largely zoonotic bacterium Yersinia enterocolitica43,44.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [42] Barton, J. C. & Acton, R. T. Hemochromatosis and Vibrio vulnificus wound infections. J. Clin. Gastroenterol. 43, 890–893 (2009). source
Not checked in the free run.
- cites [43] Bergmann, T. K., Vinding, K. & Hey, H. Multiple hepatic abscesses due to Yersinia enterocolitica infection secondary to primary haemochromatosis. Scand. J. Gastroenterol. 36, 891–895 (2001). source
Not checked in the free run.
- cites [44] Hopfner, M. et al. Yersinia enterocolitica infection with multiple liver abscesses uncovering a primary hemochromatosis. Scand. J. Gastroenterol. 36, 220–224 (2001). source
Not checked in the free run.
- Premisenone given
Throughout its physiological range, iron remains tightly bound to transferrin, making it inaccessible to microbial ferric transporters.
“However, throughout its physiological range of concentrations, the iron remains tightly bound to transferrin, making the iron inaccessible to microbial ferric transporters.”
Quote in the paperNot a substantial claim - Premisecitation
Iron deficiency is protective against high-grade parasitaemia and severe malaria.
“Epidemiological evidence suggests that iron deficiency is remarkably protective against high-grade parasitaemia and severe malaria64,65, perhaps explaining why more effective iron absorption and storage mechanisms conferred by haemochromatosis mutations are less common in the tropical regions than in northern Europe.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Gwamaka, M. et al. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 54, 1137–1144 (2012). source
Not checked in the free run.
- cites [65] Kabyemela, E. R., Fried, M., Kurtis, J. D., Mutabingwa, T. K. & Duffy, P. E. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J. Infect. Dis. 198, 163–166 (2008). source
Not checked in the free run.
- Premisecitation
The protective effect of iron deficiency against malaria is reversed by iron supplementation.
“The protective effect of iron deficiency is reversed by iron supplementation.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [64] Gwamaka, M. et al. Iron deficiency protects against severe Plasmodium falciparum malaria and death in young children. Clin. Infect. Dis. 54, 1137–1144 (2012). source
Not checked in the free run.
- cites [65] Kabyemela, E. R., Fried, M., Kurtis, J. D., Mutabingwa, T. K. & Duffy, P. E. Decreased susceptibility to Plasmodium falciparum infection in pregnant women with iron deficiency. J. Infect. Dis. 198, 163–166 (2008). source
Not checked in the free run.
- Premisecitation
Prolonged activation of hepcidin during infection and inflammation causes anaemia of inflammation, partly by restricting iron supply to the erythropoietic bone marrow.
“Prolonged activation of this mechanism during infection and inflammation imposes a biological cost in the form of anaemia of inflammation27–29, a condition that is partly caused by the restriction of iron supply to the erythropoietic bone marrow.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [27] Goodnough, L. T., Nemeth, E. & Ganz, T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116, 4754–4761 (2010). source
Not checked in the free run.
- cites [28] Kim, A. et al. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 123, 1129–1136 (2014). source
Not checked in the free run.
- cites [29] Gardenghi, S. et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 123, 1137–1145 (2014). References 28 and 29 show that IL-6 and hepcidin are important but not exclusive mediators of anaemia of inflammation in a mouse model of severe anaemia induced by heat-killed bacteria. source
Not checked in the free run.
- Premisecitation
Patients with iron overload associated with β-thalassaemia are at increased risk of infection with siderophilic bacteria.
“Patients with iron overload associated with β-thalassaemia are also at increased risk of infection with siderophilic bacteria48,49, as well as other infections, although the evidence for these associations is less conclusive48,50,51.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [48] Vento, S., Cainelli, F. & Cesario, F. Infections and thalassaemia. Lancet Infect. Dis. 6, 226–233 (2006). source
Not checked in the free run.
- cites [49] Wang, S. C. et al. Severe bacterial infection in transfusion-dependent patients with thalassemia major. Clin. Infect. Dis. 37, 984–988 (2003). source
Not checked in the free run.
- Premisenone given
During infection, plasma iron may decrease from the normal range of 10-30 μM to as low as 1-3 μM.
“During infection, the iron concentration in the plasma may decrease from the normal range of 10–30 μM to as low as 1–3 μM.”
Quote in the paperNot a substantial claim - Premisecitation
Mice lacking siderocalin die more often from septicaemia after infection with Gram-negative bacteria.
“The loss of siderocalin in mice causes increased mortality from septicaemia following infection with Gram-negative bacteria74.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [74] Flo, T. H. et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 432, 917–921 (2004). source
Not checked in the free run.
- Interpretationreasoning
In mice, siderocalin and NRAMP1 each make distinct contributions to host defence.
“Studies in mutant mice have revealed that siderocalin and NRAMP1 have demonstrable non-redundant roles in host defence.”
Quote in the paperSubstantial claim - Interpretationcitation
Iron sequestration in macrophages driven by hepcidin may, paradoxically, make iron more available to intracellular microbes such as Leishmania, Chlamydia, Legionella, and S. Typhimurium.
“Hepcidin-induced iron sequestration in macrophages (FIG. 3) may paradoxically enhance iron availability for intracellular microorganisms, including Leishmania spp.86, Chlamydia spp. and Legionella spp.87, as well as S. Typhimurium88.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [86] Ben-Othman, R. et al. Leishmania-mediated inhibition of iron export promotes parasite replication in macrophages. PLoS Pathog. 10, e1003901 (2014). source
Not checked in the free run.
- cites [87] Paradkar, P. N. et al. Iron depletion limits intracellular bacterial growth in macrophages. Blood 112, 866–874 (2008). source
Not checked in the free run.
- cites [88] Kim, D. K. et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20, 419–424 (2014). source
Not checked in the free run.
- Premisecitation
A loss-of-function NRAMP1 mutation makes mice more vulnerable to certain intracellular infections that target macrophages.
“Mice with a loss-of-function mutation in the divalent metal transporter NRAMP1 show increased susceptibility to specific intracellular infections that target macrophages72 (TABLE 4).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Canonne-Hergaux, F., Gruenheid, S., Govoni, G. & Gros, P. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc. Assoc. Am. Physicians 111, 283–289 (1999). source
Not checked in the free run.
- Interpretationreasoning
Intracellular microbes may benefit from living in macrophage erythrophagocytic vacuoles, since red blood cells contain the most iron.
“Erythrocytes are by far the richest source of iron, and therefore residence in erythrophagocytic vacuoles of macrophages might be particularly advantageous for intracellular microorganisms.”
Quote in the paperSubstantial claim- Rests on an assumption: Red blood cells are by far the richest source of iron.
- Premisecitation
IFNγ exposure lowers TFR1 levels in macrophages during intracellular infections.
“By contrast, macrophage expression of TFR1, which mediates iron delivery to endosomes, is decreased by IFNγ exposure during intracellular infections73.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [73] Byrd, T. F. & Horwitz, M. A. Interferon gamma-activated human monocytes downregulate transferrin receptors and inhibit the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. J. Clin. Invest. 83, 1457–1465 (1989). source
Not checked in the free run.
- Premisecitation
Pathogenic Gram-negative bacteria highly adapted to humans have evolved mechanisms to hijack human iron-containing proteins (transferrin, lactoferrin, haemoglobin, ferritin) as iron sources.
“Pathogenic Gram-negative bacteria (such as Neisseria meningitidis, Neisseria gonorrhoeae and Haemophilus influenzae), which are highly adapted to their human hosts, have evolved specific mechanisms for hijacking various iron-containing human proteins (such as transferrin, lactoferrin, haemoglobin and ferritin) as a source of iron80–82.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [80] Perkins-Balding, D., Ratliff-Griffin, M. & Stojiljkovic, I. Iron transport systems in Neisseria meningitidis. Microbiol. Mol. Biol. Rev. 68, 154–171 (2004). source
Not checked in the free run.
- cites [81] Alcantara, J., Yu, R. H. & Schryvers, A. B. The region of human transferrin involved in binding to bacterial transferrin receptors is localized in the C-lobe. Mol. Microbiol. 8, 1135–1143 (1993). source
Not checked in the free run.
- cites [82] Larson, J. A., Howie, H. L. & So, M. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol. Microbiol. 53, 807–820 (2004). source
Not checked in the free run.
- Premisecitation
In mice lacking hepcidin, minihepcidins successfully treated severe V. vulnificus infection.
“These agents were effective against fulminant V. vulnificus infection in hepcidin-deficient mice52.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015). This study shows that hepcidin-deficient mice are rapidly killed by V. vulnificus , but mice can be saved by the administration of minihepcidin, demonstrating the protective effect of hypoferraemia. source
Not checked in the free run.
- Interpretationreasoning
The protective impact of hepcidin-induced hypoferraemia against extracellular microorganisms is likely much broader than currently realized.
“It is therefore likely that the protective impact of this mechanism against extracellular microorganisms is much broader than we currently realize.”
Quote in the paperNot a substantial claim - Premisecitation
Human NRAMP1 variants correlate with a higher risk of tuberculosis.
“NRAMP1 variants are associated with an increased risk of tuberculosis in humans75, supporting an important contribution of this mechanism to resistance against intracellular infections.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [75] Li, X. et al. SLC11A1 (NRAMP1) polymorphisms and tuberculosis susceptibility: updated systematic review and meta-analysis. PLoS ONE 6, e15831 (2011). source
Not checked in the free run.
- Premisecitation
In primary hepatocytes, the nuclear receptor ESRRγ, which IL-6 induces, boosts hepcidin induction by IL-6.
“A recent study88 indicated that the IL-6-inducible nuclear receptor ESRRγ enhances hepcidin induction in response to IL-6 in primary hepatocytes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Kim, D. K. et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20, 419–424 (2014). source
Not checked in the free run.
- Interpretationreasoning
In response, pathogens have developed ways to overcome iron sequestration and multiply inside the host.
“In turn, pathogenic microorganisms have evolved mechanisms that counter iron sequestration and allow microbial proliferation within the host.”
Quote in the paperSubstantial claim - Interpretationreasoning
Body surface tissues and innate immune cells express other molecules that relocate and sequester iron and may function in host defence.
“the tissues and cells of body surfaces and innate immune cells express other molecules that relocate and sequester iron in its various forms and that may function in host defence (TABLE 4).”
Quote in the paperSubstantial claim - Premisecitation
Sequence and structural data from hominid transferrins indicate an evolutionary arms race between bacterial receptors and the human C-lobe of transferrin.
“Analysis of hominid transferrin sequences and structures has yielded evidence of a mutational ‘arms race’ between bacterial receptors evolving to bind and take up transferrin as a source of iron, whereas the human C-lobe of transferrin, which is targeted by these receptors84, has evolved mutational variants that escape uptake by these bacteria.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [84] Barber, M. F. & Elde, N. C. Escape from bacterial iron piracy through rapid evolution of transferrin. Science 346, 1362–1366 (2014). Evolutionary and structural evidence shows that primates and some of their highly adapted pathogens engage in a mutational 'tug-of-war' over iron availability. source
Not checked in the free run.
- Premisenone given
Iron is required as a cofactor for enzymes that mediate oxygen-dependent prolyl and asparaginyl hydroxylation of HIF1α, leading to proteasomal degradation of HIF1α.
“Iron is a required cofactor for enzymes that mediate oxygen-dependent prolyl and asparaginyl hydroxylation of hypoxia-inducible factor 1α (HIF1α), which leads to proteasomal degradation of this transcription factor.”
Quote in the paperSubstantial claim - Premisecitation
Mouse S. Typhimurium studies suggest that nitric oxide produced in response to IFNγ and bacteria can counteract hepcidin's post-translational suppression of ferroportin by raising ferroportin gene transcription.
“evidence from mouse models of S. Typhimurium infection suggests that during infections with intracellular microorganisms, the post-translational downregulation of ferroportin by hepcidin may be opposed by the effects of IFNγ- and bacteria-stimulated nitric oxide production92, which increases transcription of the gene encoding ferroportin (FIG. 3).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [92] Nairz, M. et al. Nitric oxide-mediated regulation of ferroportin-1 controls macrophage iron homeostasis and immune function in Salmonella infection. J. Exp. Med. 210, 855–873 (2013). Despite increased hepcidin levels favouring iron retention in macrophages during Salmonella infection, local production of IFNγ, nitric oxide and nuclear factor erythroid 2-related factor 2 induces increased macrophage expression of ferroportin, restricting pathogen access to iron. source
Not checked in the free run.
- Interpretationreasoning
Because bioavailable iron is scarce, host defences have evolved to target iron and restrict how much of this essential metal microbes can obtain.
“The scarcity of bioavailable iron has made iron a target of a variety of host defence mechanisms that limit the extent to which microbial invaders can access this essential trace metal.”
Quote in the paperSubstantial claim - Premisecitation
Because microbes multiply rapidly and undergo clonal selection, they can escape growth-limiting conditions such as host iron sequestration.
“Rapid microbial multiplication and clonal selection allow microorganisms to evade conditions that restrict their growth, including iron sequestration by their hosts79.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [79] Cassat, J. E. & Skaar, E. P. Iron in infection and immunity. Cell Host Microbe 13, 509–519 (2013). A complementary review of the role of iron in innate immunity, with a predominant focus on microbial iron uptake mechanisms. source
Not checked in the free run.
- Premisecitation
Some microbes can alter their siderophores so that host siderocalin cannot sequester them.
“As an example of another evasive microbial strategy, microorganisms may modify their siderophores85 to avoid their sequestration by host-derived siderocalin.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [85] Fischbach, M. A., Lin, H., Liu, D. R. & Walsh, C. T. How pathogenic bacteria evade mammalian sabotage in the battle for iron. Nat. Chem. Biol. 2, 132–138 (2006). source
Not checked in the free run.
- May combine two claims. 36
- Classified as probably not a substantial claim. 6
- The quote only partly states this claim. 1
May combine two claims.
PremisecitationSusceptibility to death from V. vulnificus infection correlates with the presence of non-transferrin-bound iron in mouse sera and with the ability of those sera to support rapid in vitro growth of V. vulnificus.
“Susceptibility to death from infection with V. vulnificus correlated with the presence of non-transferrin-bound iron in the mouse sera and with the ability of sera from these mice to support rapid in vitro growth of V. vulnificus.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015). This study shows that hepcidin-deficient mice are rapidly killed by V. vulnificus , but mice can be saved by the administration of minihepcidin, demonstrating the protective effect of hypoferraemia. source
Not checked in the free run.
May combine two claims.
PremisecitationInfection and inflammation induce hepcidin production, which lowers plasma iron by inhibiting iron absorption and promoting iron sequestration in macrophages.
“Infection and inflammation induce hepcidin production, driving a decrease in plasma iron concentrations by inhibiting the absorption of iron and promoting the sequestration of iron in macrophages.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [26] Nicolas, G. et al. The gene encoding the iron regulatory peptide hepcidin is regulated by anemia, hypoxia, and inflammation. J. Clin. Invest. 110, 1037–1044 (2002). source
Not checked in the free run.
- cites [27] Goodnough, L. T., Nemeth, E. & Ganz, T. Detection, evaluation, and management of iron-restricted erythropoiesis. Blood 116, 4754–4761 (2010). source
Not checked in the free run.
May combine two claims.
PremisecitationLactic acid bacteria have little or no requirement for iron and thrive in the iron-poor environment of the human intestine, but may be displaced by other microorganisms when iron is administered.
“Lactic acid bacteria (also known as Lactobacillales) are normal components of the intestinal flora and have little or no requirement for iron; they thrive in the relatively iron-poor environment of the human intestine, but they may be displaced by other microorganisms when iron is administered60.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [60] Bailey, J. R., Probert, C. S. & Cogan, T. A. Identification and characterisation of an iron-responsive candidate probiotic. PLoS ONE 6, e26507 (2011). source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
InterpretationcitationThe role of IREBPs in host defence and inflammation is minor, or the two IREBPs have mostly overlapping functions.
“However, the local and systemic responses to aseptic inflammation in vivo are preserved in the absence of either of the two IREBPs3, which suggests that the role of the IREBPs in host defence and inflammation is minor or that the two IREBPs have mostly overlapping functions, an issue that needs to be examined further.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [3] Viatte, L., Grone, H. J., Hentze, M. W. & Galy, B. In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation. J. Mol. Med. 87, 913–921 (2009). source
Not checked in the free run.
May combine two claims.
PremisereasoningNon-transferrin-bound iron can amplify tissue injury by catalysing extracellular ROS production or by being rapidly taken up by some cell types, causing cellular iron overload and secondary ROS generation.
“Moreover, non-transferrin-bound iron can amplify tissue injury either because it catalyses the extracellular production of injurious reactive oxygen species (ROS) or because it is rapidly taken up some cell types, causing cellular iron overload with the secondary generation of ROS.”
Quote in the paperSubstantial claim- Rests on an assumption: Malarial parasites require iron at both the liver and erythrocyte stages.
May combine two claims.
InterpretationcitationThis mechanism may prevent superinfection by additional malaria parasites during subsequent exposures and provides innate immune protection in infants and children without adaptive immunity.
“This mechanism may function to prevent superinfection by additional malaria parasites during subsequent exposures to malaria-bearing mosquitoes, and it provides a form of innate immune protection in infants and children who have not yet developed an adaptive immune response to malarial parasites31.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [31] Portugal, S. et al. Host-mediated regulation of superinfection in malaria. Nat. Med. 17, 732–737 (2011). In pre-immune children, malaria parasitaemia induces hepcidin expression and redistributes iron from hepatocytes to macrophages, thereby interfering with the hepatic stage of superinfection by another malarial strain. source
Not checked in the free run.
May combine two claims.
PremisereasoningTissue iron overload and resulting toxicity is proportional to the severity and duration of hepcidin deficiency, and results in progressive damage to the liver, endocrine glands and cardiac myocytes.
“Tissue iron overload and resulting toxicity is proportional to the severity and duration of hepcidin deficiency, and results in progressive iron-mediated damage to the liver, endocrine glands and cardiac myocytes.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationMost bacterial and some viral infections (influenza, HIV) rapidly increase hepcidin production in humans and mouse models, whereas hepatitis B and C virus infections fail to elicit systemic inflammatory responses and hepcidin production.
“Interestingly, although most bacterial and some viral infections (such as influenza virus and HIV) rapidly increase hepcidin production in humans and mouse models, hepatitis B and hepatitis C virus infections fail to elicit systemic inflammatory responses and hepcidin production30.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [30] Armitage, A. E. et al. Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections. Proc. Natl Acad. Sci. USA 111, 12187–12192 (2014). This study shows that not all infections induce hepcidin: no induction of hepcidin or hypoferraemia was observed during the viraemic phase of hepatitis B or hepatitis C virus infection. source
Not checked in the free run.
Classified as probably not a substantial claim.
Premisenone givenHepcidin is the main iron-regulatory hormone acting on ferroportin to modulate iron absorption and systemic iron distribution.
“The role of hepcidin as the iron-regulatory hormone that acts on ferroportin to modulate iron absorption and systemic iron distribution is now well accepted, but the strong connection between hepcidin and host defence is less well appreciated.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningIron depletion of macrophages could mimic hypoxia by stabilizing HIF1α and promoting transcription and synthesis of IL-1β and perhaps other cytokines.
“Iron depletion of macrophages could therefore mimic the effects of hypoxia, stabilizing HIF1α and promoting the transcription and synthesis of IL-1β68 and perhaps other cytokines.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [68] Peyssonnaux, C. et al. Cutting edge: essential role of hypoxia inducible factor-1α in development of lipopolysaccharide-induced sepsis. J. Immunol. 178, 7516–7519 (2007). source
Not checked in the free run.
May combine two claims. The quote only partly states this claim.
PremisecitationMalaria infection causes inflammation and increases hepcidin levels, redistributing iron to macrophages and away from hepatocytes that support the initial stage of infection.
“Malaria infection causes inflammation and increases hepcidin levels, redistributing iron to macrophages and, in the long term, away from hepatocytes that normally support the initial stage of infection.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Premisenone givenHepcidin has direct antimicrobial activity in vitro, but the concentrations and conditions required seem outside the physiological range.
“Also similar to defensins, hepcidin has direct antimicrobial activity in vitro, but the concentrations and conditions required for this activity seem to be outside of the physiological range.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationIn ex vivo erythrocytes from iron-deficient donors, P. falciparum invades fewer cells and grows more slowly intracellularly than in erythrocytes from iron-replete donors.
“In ex vivo erythrocytes from iron-deficient donors, the malarial parasite Plasmodium falciparum invades fewer cells and shows slower intracellular growth than in erythrocytes from iron-replete donors66.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [66] Clark, M. A. et al. Host iron status and iron supplementation mediate susceptibility to erythrocytic stage Plasmodium falciparum. Nat. Commun. 5, 4446 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationIL-1β mediates systemic inflammation and activates important host defence mechanisms.
“IL-1β mediates systemic inflammation and activates important host defence mechanisms69.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] Horino, T. et al. Interleukin-1-deficient mice exhibit high sensitivity to gut-derived sepsis caused by Pseudomonas aeruginosa. Cytokine 30, 339–346 (2005). source
Not checked in the free run.
May combine two claims.
PremisecitationExogenous hepcidin is protective against renal ischaemia-reperfusion injury and oxidative stress, and hepcidin deficiency exacerbates these forms of injury.
“Indeed, a recent study showed that exogenous hepcidin is protective against renal ischaemia–reperfusion injury and oxidative stress, and that hepcidin deficiency exacerbates these forms of injury32.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [32] Scindia, Y. et al. Hepcidin mitigates renal ischemia–reperfusion injury by modulating systemic iron homeostasis. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2014101037 (2015). source
Not checked in the free run.
May combine two claims.
PremisecitationSome but not all studies found altered composition of intestinal flora and increased inflammation in children treated to prevent or reverse iron deficiency.
“Motivated to understand the connection between iron supplementation and diarrhoeal illness in African children, some but not all studies found an altered composition of the intestinal flora and increased inflammation in children who were treated to prevent or reverse iron deficiency61–63.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [61] Zimmermann, M. B. et al. The effects of iron fortification on the gut microbiota in African children: a randomized controlled trial in Cote d'Ivoire. Am. J. Clin. Nutr. 92, 1406–1415 (2010). source
Not checked in the free run.
- cites [62] Jaeggi, T. et al. Iron fortification adversely affects the gut microbiome, increases pathogen abundance and induces intestinal inflammation in Kenyan infants. Gut 64, 731–742 (2015). source
Not checked in the free run.
- cites [63] Dostal, A. et al. Effects of iron supplementation on dominant bacterial groups in the gut, faecal SCFA and gut inflammation: a randomised, placebo-controlled intervention trial in South African children. Br. J. Nutr. 112, 547–556 (2014). source
Not checked in the free run.
May combine two claims.
PremisecitationErythroferrone is produced by erythroblasts in response to erythropoietic stimulation and suppresses hepcidin synthesis, making more iron available for erythropoiesis.
“Another set of regulatory factors conveys the iron requirements for erythropoiesis and includes the recently identified hormone erythroferrone12, which is produced by erythroblasts in response to erythropoietic stimulation by endogenous or synthetic erythropoietin. Erythroferrone suppresses hepcidin synthesis, making more iron available for enhanced erythropoiesis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] Kautz, L. et al. Identification of erythroferrone as an erythroid regulator of iron metabolism. Nat. Genet. 46, 678–684 (2014). source
Not checked in the free run.
May combine two claims.
InterpretationcitationHepcidin causes iron sequestration in macrophages and would be expected to have an anti-inflammatory effect.
“Although the induction of IL-1β is not primarily modulated by hepcidin, hepcidin causes iron sequestration in macrophages (FIG. 3) and would be expected to have an anti-inflammatory effect67.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [67] Pagani, A. et al. Low hepcidin accounts for the proinflammatory status associated with iron deficiency. Blood 118, 736–746 (2011). source
Not checked in the free run.
May combine two claims.
Premisenone givenCellular iron overload increases ROS production, causing cellular injury.
“Cellular iron overload increases the production of ROS, causing cellular injury.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationInfections with intracellular microorganisms that reside in macrophages may be enhanced by hepcidin-induced iron sequestration, and hepcidin deficiency in mouse models of hereditary haemochromatosis may inhibit growth of macrophage-resident bacteria including M. tuberculosis and S. Typhimurium.
“Paradoxically, studies in mouse models have shown that infections with intracellular microorganisms that reside in macrophages may be enhanced by hepcidin-induced iron sequestration, and conversely, hepcidin deficiency in mouse models of hereditary haemochromatosis may inhibit the growth of macrophage-resident bacteria, including Mycobacteria tuberculosis53 or Salmonella enterica serovar enterica”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [53] Olakanmi, O., Schlesinger, L. S. & Britigan, B. E. Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages. J. Leukoc. Biol. 81, 195–204 (2007). source
Not checked in the free run.
- cites [54] Nairz, M. et al. Absence of functional Hfe protects mice from invasive Salmonella enterica serovar Typhimurium infection via induction of lipocalin-2. Blood 114, 3642–3651 (2009). References 53 and 54 raise the possibility that hepcidin deficiency, while promoting certain extracellular infections, may be protective against intracellular pathogens. source
Not checked in the free run.
May combine two claims.
PremisecitationMice lacking hepcidin fail to develop hypoferraemia after inflammatory stimulation, may have increased serum iron during infection/inflammation, and have milder anaemia of inflammation.
“Mice engineered to lack hepcidin fail to develop hypoferraemia after inflammatory stimulation, their serum iron concentrations may even increase during infection or inflammation, and their anaemia of inflammation is milder28,29.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [28] Kim, A. et al. A mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin. Blood 123, 1129–1136 (2014). source
Not checked in the free run.
- cites [29] Gardenghi, S. et al. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 123, 1137–1145 (2014). References 28 and 29 show that IL-6 and hepcidin are important but not exclusive mediators of anaemia of inflammation in a mouse model of severe anaemia induced by heat-killed bacteria. source
Not checked in the free run.
May combine two claims.
PremisecitationAnaemia due to ineffective erythropoiesis, as in β-thalassaemia, is associated with severe iron overload even without transfusions, but is exacerbated by repeated transfusions.
“Anaemia owing to ineffective erythropoiesis, as occurs most prominently in patients with β-thalassaemia, is associated with severe iron overload that develops even in the absence of blood transfusions but is exacerbated in patients who receive repeated transfusions36,37.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [36] Musallam, K. M., Cappellini, M. D. & Taher, A. T. Iron overload in β-thalassemia intermedia: an emerging concern. Curr. Opin. Hematol. 20, 187–192 (2013). source
Not checked in the free run.
- cites [37] Maggio, A. et al. Iron chelation therapy in thalassemia major: a systematic review with meta-analyses of 1520 patients included on randomized clinical trials. Blood Cells Mol. Dis. 47, 166–175 (2011). source
Not checked in the free run.
May combine two claims.
InterpretationcitationNRAMP1 likely transports iron from phagosomes and other microorganism-containing vacuoles to macrophage cytoplasm, thereby starving vacuolar microorganisms of iron.
“most studies suggest that NRAMP1 transports iron from phagosomes and other vacuoles that contain microorganisms to the cytoplasm of macrophages76–78, thereby starving vacuolar microorganisms of iron.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [76] Soe-Lin, S. et al. Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo. Proc. Natl Acad. Sci. USA 106, 5960–5965 (2009). source
Not checked in the free run.
- cites [77] Cellier, M. F., Courville, P. & Campion, C. Nramp1 phagocyte intracellular metal withdrawal defense. Microbes Infect. 9, 1662–1670 (2007). source
Not checked in the free run.
- cites [78] Forbes, J. R. & Gros, P. Iron, manganese, and cobalt transport by Nramp1 (Slc11a1) and Nramp2 (Slc11a2) expressed at the plasma membrane. Blood 102, 1884–1892 (2003). source
Not checked in the free run.
May combine two claims.
PremisecitationThe response to S. Typhimurium requires both IL-6 and ESRRγ.
“S. Typhimurium elicits this response by a mechanism that is dependent on IL-6 and oestrogen-related receptor-γ (ESRRγ)88.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Kim, D. K. et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20, 419–424 (2014). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSuch macrophages supply bacteria with iron obtained through erythrophagocytosis and create an M2-like setting with weakened antimicrobial activity, which helps the bacteria survive.
“In this way, these macrophages provide the bacteria with a source of iron from erythrophagocytosis and an M2 macrophage environment with attenuated antimicrobial mechanisms favouring the survival of the bacteria.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIFNγ raises NRAMP1 levels, and iron export from phagosomes by NRAMP1 might partially offset systemic hepcidin.
“NRAMP1 expression is also stimulated by IFNγ72, and NRAMP1-mediated iron export from phagosomes containing intracellular microorganisms may help to counter the effect of systemic hepcidin.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [72] Canonne-Hergaux, F., Gruenheid, S., Govoni, G. & Gros, P. The Nramp1 protein and its role in resistance to infection and macrophage function. Proc. Assoc. Am. Physicians 111, 283–289 (1999). source
Not checked in the free run.
May combine two claims.
PremisecitationTo work, an iron chelator must be safe, bind ferric iron more strongly than bacterial siderophores do, and escape recognition by microbial siderophore transporters.
“An effective iron chelator must be nontoxic, must have higher affinity for ferric iron than bacterial siderophores and must not be recognized by microbial siderophore transporters94.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [94] Zhou, T., Ma, Y., Kong, X. & Hider, R. C. Design of iron chelators with therapeutic application. Dalton Trans. 41, 6371–6389 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationIron deficiency is widespread in developing countries and is a major cause of chronic illness and loss of economic productivity.
“Iron deficiency is widespread in developing countries and is a major cause of chronic illness and loss of economic productivity56.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [56] Pasricha, S. R., Drakesmith, H., Black, J., Hipgrave, D. & Biggs, B. A. Control of iron deficiency anemia in low- and middle-income countries. Blood 121, 2607–2617 (2013). source
Not checked in the free run.
May combine two claims.
PremisecitationNeisseria species take up transferrin only from hominids, a specificity that helps them live in humans and some other hominids.
“The uptake of transferrin by Neisseria species is specific to hominid transferrin, indicating that this specialized uptake mechanism facilitates their residence in the human host and several other hominids83.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [83] Noinaj, N. et al. Structural basis for iron piracy by pathogenic Neisseria. Nature 483, 53–58 (2012). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningThese mice still become hypoferraemic, which suggests the nitric oxide effect is local and needs intracellular bacteria, so hepcidin remains the main regulator in most iron-recycling macrophages.
“Nevertheless, these mice develop hypoferraemia, indicating that the nitric oxide-dependent mechanism operates at a local level and requires the presence of bacteria within the macrophage, leaving most iron-recycling macrophages under the dominant regulatory influence of hepcidin.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationIn that model, mini-hepcidins quickly lowered iron in plasma and extracellular fluid, reducing non-transferrin-bound iron, which probably feeds siderophilic bacteria.
“In this model, mini-hepcidins rapidly decreased iron concentrations in the plasma and extracellular fluid, and thereby decreased the concentrations of non-transferrin-bound iron, which is a likely source of iron for siderophilic bacteria.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [52] Arezes, J. et al. Hepcidin-induced hypoferremia is a critical host defense mechanism against the siderophilic bacterium Vibrio vulnificus. Cell Host Microbe 17, 47–57 (2015). This study shows that hepcidin-deficient mice are rapidly killed by V. vulnificus , but mice can be saved by the administration of minihepcidin, demonstrating the protective effect of hypoferraemia. source
Not checked in the free run.
May combine two claims.
PremisecitationDuring chronic S. Typhimurium infection, the bacteria might trigger erythrophagocytosis and shift liver and spleen macrophages toward an M2 phenotype; host signals are also needed, but the molecular details are unknown.
“In chronic infection with S. Typhimurium, the bacteria may induce erythrophagocytosis and the conversion of hepatic and splenic macrophages into an M2 phenotype, a process that also requires host signals but has not been characterized in molecular detail93.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [93] Pilonieta, M. C., Moreland, S. M., English, C. N. & Detweiler, C. S. Salmonella enterica infection stimulates macrophages to hemophagocytose. mBio 5, e02211 (2014). source
Not checked in the free run.
May combine two claims.
InterpretationreasoningDuring intracellular infections, the hepcidin-ferroportin axis appears harmful, yet local mechanisms in infected macrophages might offset systemic hepcidin.
“Although the hepcidin–ferroportin system seems to function maladaptively during infections with intracellular microorganisms, this host response could be mitigated in infected macrophages by local mechanisms that counteract the systemic effects of hepcidin.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMost microbial infections raise IL-6 early; IL-6 then drives hepcidin transcription through JAK2-STAT3, requiring STAT3-binding sites in the HAMP promoter.
“IL-6 is increased early in most microbial infections and it stimulates hepcidin transcription via the JAK2–STAT3 pathway in a manner dependent on STAT3-binding motifs in the promoter of HAMP (the hepcidin gene)89–91.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [89] Wrighting, D. M. & Andrews, N. C. Interleukin-6 induces hepcidin expression through STAT3. Blood 108, 3204–3209 (2006). source
Not checked in the free run.
- cites [90] Fleming, R. E. Hepcidin activation during inflammation: make it STAT. Gastroenterology 132, 447–449 (2007). source
Not checked in the free run.
- cites [91] Pietrangelo, A. et al. STAT3 is required for IL-6-gp130-dependent activation of hepcidin in vivo. Gastroenterology 132, 294–300 (2007). source
Not checked in the free run.
May combine two claims.
PremisecitationDespite decades of work, three approved drugs for iron overload, and in vitro microbistatic evidence for some compounds, no chelator is yet used as an antimicrobial therapy.
“Despite several decades of research in this area that have yielded three successful drugs for the treatment of iron overload disorders, and evidence of in vitro microbistatic activity for several compounds95, no chelator has yet been adopted as an antimicrobial therapeutic.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [95] Thompson, M. G., Corey, B. W., Si, Y., Craft, D. W. & Zurawski, D. V. Antibacterial activities of iron chelators against common nosocomial pathogens. Antimicrob. Agents Chemother. 56, 5419–5421 (2012). source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationA direct hepcidin-mediated anti-inflammatory effect mediated by ferroportin and the JAK-STAT pathway was proposed, but JAK-STAT-mediated signalling by ferroportin was not confirmed in subsequent more-detailed studies.
“A direct hepcidin-mediated anti-inflammatory effect mediated by ferroportin and the Janus kinase (JAK)–signal transducer and activator of transcription (STAT) pathway was proposed70, but JAK–STAT-mediated signalling by ferroportin was not confirmed in subsequent more-detailed studies71.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [70] De Domenico, I. et al. Hepcidin mediates transcriptional changes that modulate acute cytokine-induced inflammatory responses in mice. J. Clin. Invest. 120, 2395–2405 (2010). source
Not checked in the free run.
- cites [71] Ross, S. L. et al. Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab. 15, 905–917 (2012). source
Not checked in the free run.
May combine two claims.
PremisecitationIn infected mice, blocking the ESRRγ pathway lowered bacterial burden significantly and improved survival modestly.
“Chemical inhibition of the ESRRγ pathway in a mouse model significantly decreased bacterial burden and modestly improved the survival of infected mice88.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [88] Kim, D. K. et al. Inverse agonist of estrogen-related receptor γ controls Salmonella typhimurium infection by modulating host iron homeostasis. Nat. Med. 20, 419–424 (2014). source
Not checked in the free run.
Classified as probably not a substantial claim.
InterpretationreasoningSince most microbes rely heavily on iron, this dependence justifies developing new antimicrobials aimed at their iron uptake systems.
“Finally, the exquisite dependence of most microorganisms on iron provides a rationale for the design of new antimicrobials that target iron uptake mechanisms in pathogenic microorganisms.”
Quote in the paperSubstantial claim- Rests on an assumption: Most microorganisms depend exquisitely on iron.
The paper relies on this without support.
Most microorganisms depend absolutely on exogenous iron for survival.
“Given the absolute dependence of most microorganisms on exogenous iron for their survival, it has been assumed that the hypoferraemia of infection and inflammation has a host defence function.”
The paper relies on this without support.
Iron is essential for nearly all microorganisms.
“Iron is also essential for nearly all microorganisms, plants and invertebrate animals, in which it functions as a catalytic component of enzymes that mediate many redox reactions that are crucial for energy production and intermediary metabolism.”
The paper relies on this without support.
Non-transferrin-bound iron can amplify tissue injury by catalysing extracellular ROS production or by rapid cellular uptake causing iron overload and secondary ROS.
“Moreover, non-transferrin-bound iron can amplify tissue injury either because it catalyses the extracellular production of injurious reactive oxygen species (ROS) or because it is rapidly taken up some cell types, causing cellular iron overload with the secondary generation of ROS.”
The paper relies on this without support.
Malarial parasites require iron at both the liver and erythrocyte stages.
“The parasites require iron at both the liver and the erythrocyte stage.”
The paper relies on this without support.
Iron deficiency is endemic in tropical regions.
“The possibility that iron deficiency, which is endemic in tropical regions, may be protective against certain infections has also been raised.”
The paper relies on this without support.
Hepcidin acts on ferroportin to shift iron into macrophages.
“In addition to hepcidin — the effects of which on ferroportin cause redistribution of iron into macrophages —”
The paper relies on this without support.
Lactoferrin, unlike transferrin, keeps binding iron at the low pH found in inflamed and infected tissues.
“Lactoferrin is a homologue of the iron carrier protein transferrin but differs from transferrin by continuing to bind iron even at low pH, which is common in inflamed and infected tissues.”
The paper relies on this without support.
Siderocalin binds iron only when it is complexed with small natural organic chelators.
“Siderocalin, a member of a family of proteins that contain a pocket (calyx) for small mostly hydrophobic molecules, binds iron when it is complexed with small natural organic chelators.”
The paper relies on this without support.
Haptoglobin and haemopexin carry free haemoglobin and haem, respectively, to macrophages and hepatocytes for degradation.
“Haptoglobin and haemopexin are carrier proteins that transport free haemoglobin and haem, respectively, for degradation by macrophages and hepatocytes.”
The paper relies on this without support.
NRAMP1 is a ferrous iron transporter located in phagocytic vacuole membranes of macrophages and neutrophils.
“NRAMP1 is a ferrous iron transporter found in the membranes of phagocytic vacuoles of macrophages and neutrophils.”
The paper relies on this without support.
Red blood cells are by far the richest source of iron.
“Erythrocytes are by far the richest source of iron”
The paper relies on this without support.
Most microorganisms depend exquisitely on iron.
“the exquisite dependence of most microorganisms on iron”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Limiting iron availability to invading pathogens is essential, as both bacterial and fungal pathogens have been shown to target haem, hemoglobin, and other iron-complex proteins.
“This is essential in limiting iron availability to invading pathogens, as both bacterial and fungal pathogens have been shown to target haem, hemoglobin, and other iron-complex proteins (Ganz and Nemeth, 2015).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Ganz and Nemeth, 2015
The Conclusions and perspectives section says host defences restrict microbial access to iron. The Microbial countermeasures section says pathogenic Gram-negative bacteria obtain iron from haemoglobin and other iron-containing human proteins. Our copy does not establish that fungal pathogens target those proteins, or specifically identify haem as a target. (LLM, conf=0.87)
Experimental — accuracy not yet measuredIron in the human host is largely unavailable as it is constantly sequestered by specialized proteins which prevent attack by ROS or exploitation by pathogens.
“Iron in the human host is largely unavailable as it is constantly sequestered by specialized proteins which prevent attack by ROS or exploitation by pathogens (Ganz and Nemeth, 2015).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Ganz and Nemeth, 2015
Systemic iron levels are tightly regulated by hepcidin (encoded by HAMP), while individual cells may independently regulate iron by receptor-mediated endocytosis of transferrin.
“Systemic iron levels are tightly regulated by iron metabolism master regulator, hepcidin (encoded by HAMP), while individual cells may independently regulate iron by receptor-mediated endocytosis of transferrin (Ganz and Nemeth, 2015).”
From Iron at the Centre of Candida albicans Interactions (2018) · cites this paper as Ganz and Nemeth, 2015
In the adaptive immune system, iron is an essential growth factor for the clonal expansion of lymphocyte subsets.
“In the adaptive immune system, iron is an essential growth-factor for the clonal expansion of lymphocyte subsets (Ganz and Nemeth, 2015;Soares and Weiss, 2015;Weiss, 2002).”
From Iron in infection and immunity (2020) · cites this paper as Ganz and Nemeth, 2015
The Abstract says iron is essential for vertebrates generally, but does not address its role in lymphocyte expansion. Searches for lymphocytes, adaptive immunity, and clonal expansion found no passage supporting the specific claim; the paper’s discussion of clonal selection concerns microorganisms. (LLM, conf=0.74)
Experimental — accuracy not yet measuredIron trafficking is controlled by cytokines and acute phase proteins, whereas iron promotes lymphocyte and macrophage differentiation, anti-microbial immune effector function, and immune cell metabolism.
“Accordingly, iron trafficking is controlled by cytokines and acute phase proteins, whereas the metal itself promotes lymphocyte and macrophage differentiation, anti-microbial immune effector function, and immune cell metabolism, as we will discuss later (Ganz and Nemeth, 2015; Soares and Weiss, 2015).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Ganz and Nemeth, 2015
This process is blocked by the action of hepcidin during times of infection to prevent iron release in the circulation, which would otherwise fuel extracellular pathogen growth.
“This process is blocked by the action of hepcidin during times of infection to prevent iron release in the circulation, which would otherwise fuel extracellular pathogen growth (Ganz and Nemeth, 2015).”
From The Role of Iron Regulation in Immunometabolism and Immune-Related Disease (2019) · cites this paper as Ganz and Nemeth, 2015
Macrophage iron metabolism and immune functions are interconnected.
“Macrophage iron metabolism and immune functions are interconnected [57, 79, 165, 247].”
From “Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels (2017) · cites this paper as [79]
Infection triggered macrophage iron retention as a host defense mechanism to withhold the nutrient iron from invading microbes.
“infection triggered macrophage iron retention as a host defense mechanism to withhold the nutrient iron from invading microbes [24,25,26]”
From Prevalence and Predictive Value of Anemia and Dysregulated Iron Homeostasis in Patients with COVID-19 Infection (2020) · cites this paper as [24]
In haemochromatosis, intestinal iron absorption is disconnected from systemic iron availability, resulting in potentially lethal iron loading and susceptibility to fatal siderophilic bacterial infections.
“In haemochromatosis, intestinal iron absorption is disconnected from systemic iron availability, resulting in potentially lethal iron loading and susceptibility to fatal siderophilic bacterial infections, which exemplify the importance of regulating intestinal iron absorption. 42 , 43”
From The battle for iron in enteric infections (2020) · cites this paper as [43]
Iron in red blood cell hemoglobin is recycled mainly by erythrophagocytic macrophages in the splenic red pulp engulfing and digesting senescent or damaged red blood cells.
“This is circumvented by the recycling of the Fe contained in the heme groups of Hb inside RBC (14–16), achieved largely via the continuous engulfment and digestion of senescent or damaged RBC by erythrophagocytic macrophages (EM) in the red pulp of the spleen (15) (Figure 1).”
From Innate Nutritional Immunity (2018) · cites this paper as [16]
Persistent chronic hypoferremia restricts iron availability for erythropoiesis.
“However, persistent chronic hypoferremia restricts iron availability for erythropoiesis (Ganz and Nemeth, 2015).”
From Pharmacological Targeting of the Hepcidin/Ferroportin Axis (2016) · cites this paper as Ganz and Nemeth, 2015
Reduction of serum transferrin appears to be one of the mechanisms of microbial iron withdrawal.
“Therefore, the reduction of serum TF appears to be one of the mechanisms of microbial iron withdrawal [54–57].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [55]
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S. N., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,834 · see citing works
Nemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · see citing works
Self-citationLipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron
Flo, T. H., Smith, K. D., Sato, S., Rodriguez, D. J., Holmes, M. A., Strong, R. K., Akira, S., & Aderem, A. (2004) · Nature · doi:10.1038/nature03104 · Cited by 1,877 · see citing works
Nicolas, G., Chauvet, C., Viatte, L., Danan, J. L., Bigard, X., Devaux, I., Beaumont, C., Kahn, A., & Vaulont, S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215686 · Cited by 1,214 · see citing works
Iron in infection and immunity
Cassat, J. E., & Skaar, E. P. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.04.010 · Cited by 1,214 · see citing works
Identification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127 · see citing works
Self-citationGanz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122 · see citing works
Self-citationInterleukin-6 induces hepcidin expression through STAT3
Wrighting, D. M., & Andrews, N. C. (2006) · Blood · doi:10.1182/blood-2006-06-027631 · Cited by 983 · see citing works
Sazawal, S., Black, R. E., Ramsan, M., Chwaya, H. M., Stoltzfus, R. J., Dutta, A., Dhingra, U., Kabole, I., Deb, S., Othman, M. K., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)67962-2 · Cited by 981 · see citing works
Iron and Its Relation to Immunity and Infectious Disease
Oppenheimer, S. J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.2.616s · Cited by 695 · see citing works
Hepcidin and the iron-infection axis
Drakesmith, H., & Prentice, A. M. (2012) · Science · doi:10.1126/science.1224577 · Cited by 686 · see citing works
Jaeggi, T., Kortman, G. A. M., Moretti, D., Chassard, C., Holding, P., Dostal, A., Boekhorst, J., Timmerman, H. M., Swinkels, D. W., Tjalsma, H., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-307720 · Cited by 622 · see citing works
Zimmermann, M. B., Chassard, C., Rohner, F., N'Goran, E. K., Nindjin, C., Dostal, A., Utzinger, J., Ghattas, H., Lacroix, C., & Hurrell, R. F. (2010) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.004564 · Cited by 520 · see citing works
Peyssonnaux, C., Cejudo-Martin, P., Doedens, A., Zinkernagel, A. S., Johnson, R. S., & Nizet, V. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7516 · Cited by 480 · see citing works
Hepcidin and disorders of iron metabolism
Ganz, T., & Nemeth, E. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050109-142444 · Cited by 466 · see citing works
Self-citationThe adverse effect of iron repletion on the course of certain infections.
Murray, M. J., Murray, A. B., Murray, M. B., & Murray, C. J. (1978) · BMJ · doi:10.1136/bmj.2.6145.1113 · Cited by 453 · see citing works
Control of iron deficiency anemia in low- and middle-income countries
Pasricha, S.-R., Drakesmith, H., Black, J., Hipgrave, D., & Biggs, B.-A. (2013) · Blood · doi:10.1182/blood-2012-09-453522 · Cited by 440 · see citing works
Detection, evaluation, and management of iron-restricted erythropoiesis
Goodnough, L. T., Nemeth, E., & Ganz, T. (2010) · Blood · doi:10.1182/blood-2010-05-286260 · Cited by 410 · see citing works
Self-citationLiver iron concentrations and urinary hepcidin in -thalassemia
Origa, R., Galanello, R., Ganz, T., Giagu, N., Maccioni, L., Faa, G., & Nemeth, E. (2007) · Haematologica · doi:10.3324/haematol.10842 · Cited by 365 · see citing works
Self-citationNutritional Immunity: Host's Attempt to Withhold Iron From Microbial Invaders
Weinberg, E. D. (1975) · JAMA · doi:10.1001/jama.1975.03240130021018 · Cited by 342 · see citing works
Iron at the interface of immunity and infection
Nairz, M., Haschka, D., Demetz, E., & Weiss, G. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00152 · Cited by 325 · see citing works
How pathogenic bacteria evade mammalian sabotage in the battle for iron
Fischbach, M. A., Lin, H., Liu, D. R., & Walsh, C. T. (2006) · Nature Chemical Biology · doi:10.1038/nchembio771 · Cited by 321 · see citing works
Byrd, T. F., & Horwitz, M. A. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114038 · Cited by 320 · see citing works
STAT3 Is Required for IL-6-gp130–Dependent Activation of Hepcidin In Vivo
Pietrangelo, A., Dierssen, U., Valli, L., Garuti, C., Rump, A., Corradini, E., Ernst, M., Klein, C., & Trautwein, C. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.10.018 · Cited by 315 · see citing works
ER Stress Controls Iron Metabolism Through Induction of Hepcidin
Vecchi, C., Montosi, G., Zhang, K., Lamberti, I., Duncan, S. A., Kaufman, R. J., & Pietrangelo, A. (2009) · Science · doi:10.1126/science.1176639 · Cited by 310 · see citing works
Hepcidin regulation by innate immune and infectious stimuli
Armitage, A. E., Eddowes, L. A., Gileadi, U., Cole, S., Spottiswoode, N., Selvakumar, T. A., Ho, L.-P., Townsend, A. R. M., & Drakesmith, H. (2011) · Blood · doi:10.1182/blood-2011-04-351957 · Cited by 294 · see citing works
Forbes, J. R., & Gros, P. (2003) · Blood · doi:10.1182/blood-2003-02-0425 · Cited by 288 · see citing works
Structural basis for iron piracy by pathogenic Neisseria
Noinaj, N., Easley, N. C., Oke, M., Mizuno, N., Gumbart, J., Boura, E., Steere, A. N., Zak, O., Aisen, P., Tajkhorshid, E., et al. (2012) · Nature · doi:10.1038/nature10823 · Cited by 262 · see citing works
Host-mediated regulation of superinfection in malaria
Portugal, S., Carret, C., Recker, M., Armitage, A. E., Gonçalves, L. A., Epiphanio, S., Sullivan, D., Roy, C., Newbold, C. I., Drakesmith, H., et al. (2011) · Nature Medicine · doi:10.1038/nm.2368 · Cited by 232 · see citing works
Pinilla-Tenas, J. J., Sparkman, B. K., Shawki, A., Illing, A. C., Mitchell, C. J., Zhao, N., Liuzzi, J. P., Cousins, R. J., Knutson, M. D., & Mackenzie, B. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00479.2010 · Cited by 228 · see citing works
Arezes, J., Jung, G., Gabayan, V., Valore, E., Ruchala, P., Gulig, P. A., Ganz, T., Nemeth, E., & Bulut, Y. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2014.12.001 · Cited by 227 · see citing works
Self-citationIron depletion limits intracellular bacterial growth in macrophages
Paradkar, P. N., De Domenico, I., Durchfort, N., Zohn, I., Kaplan, J., & Ward, D. M. (2008) · Blood · doi:10.1182/blood-2007-12-126854 · Cited by 216 · see citing works
Vento, S., Cainelli, F., & Cesario, F. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70437-6 · Cited by 211 · see citing works
Zhao, N., Zhang, A., & Enns, C. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67225 · Cited by 210 · see citing works
Nairz, M., Schleicher, U., Schroll, A., Sonnweber, T., Theurl, I., Ludwiczek, S., Talasz, H., Brandacher, G., Moser, P. L., Muckenthaler, M. U., et al. (2013) · Journal of Experimental Medicine · doi:10.1084/jem.20121946 · Cited by 204 · see citing works
Nramp1 phagocyte intracellular metal withdrawal defense
Cellier, M. F., Courville, P., & Campion, C. (2007) · Microbes and Infection · doi:10.1016/j.micinf.2007.09.006 · Cited by 203 · see citing works
Iron Deficiency Protects Against Severe Plasmodium falciparum Malaria and Death in Young Children
Gwamaka, M., Kurtis, J. D., Sorensen, B. E., Holte, S., Morrison, R., Mutabingwa, T. K., Fried, M., & Duffy, P. E. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis010 · Cited by 197 · see citing works
De Domenico, I., Zhang, T. Y., Koening, C. L., Branch, R. W., London, N., Lo, E., Daynes, R. A., Kushner, J. P., Li, D., Ward, D. M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42011 · Cited by 197 · see citing works
Besson-Fournier, C., Latour, C., Kautz, L., Bertrand, J., Ganz, T., Roth, M.-P., & Coppin, H. (2012) · Blood · doi:10.1182/blood-2012-02-411470 · Cited by 179 · see citing works
Self-citationEscape from bacterial iron piracy through rapid evolution of transferrin
Barber, M. F., & Elde, N. C. (2014) · Science · doi:10.1126/science.1259329 · Cited by 177 · see citing works
Urinary hepcidin in congenital chronic anemias
Kearney, S. L., Nemeth, E., Neufeld, E. J., Thapa, D., Ganz, T., Weinstein, D. A., & Cunningham, M. J. (2007) · Pediatric Blood & Cancer · doi:10.1002/pbc.20616 · Cited by 172 · see citing works
Self-citationIron Transport Systems in <i>Neisseria meningitidis</i>
Perkins-Balding, D., Ratliff-Griffin, M., & Stojiljkovic, I. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.1.154-171.2004 · Cited by 172 · see citing works
Nramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo
Soe-Lin, S., Apte, S. S., Andriopoulos, B., Andrews, M. C., Schranzhofer, M., Kahawita, T., Garcia-Santos, D., & Ponka, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900808106 · Cited by 167 · see citing works
The Nramp1 Protein and Its Role in Resistance to Infection and Macrophage Function
Canonne‐Hergaux, F., Gruenheid, S., Govoni, G., & Gros, P. (1999) · Proceedings of the Association of American Physicians · doi:10.1046/j.1525-1381.1999.99236.x · Cited by 159 · see citing works
Kim, D.-K., Jeong, J.-H., Lee, J.-M., Kim, K. S., Park, S.-H., Kim, Y. D., Koh, M., Shin, M., Jung, Y. S., Kim, H.-S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3483 · Cited by 148 · see citing works
Nairz, M., Theurl, I., Schroll, A., Theurl, M., Fritsche, G., Lindner, E., Seifert, M., Crouch, M.-L. V., Hantke, K., Akira, S., et al. (2009) · Blood · doi:10.1182/blood-2009-05-223354 · Cited by 146 · see citing works
Ross, S. L., Tran, L., Winters, A., Lee, K.-J., Plewa, C., Foltz, I., King, C., Miranda, L. P., Allen, J., Beckman, H., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.03.017 · Cited by 145 · see citing works
Self-citationA mouse model of anemia of inflammation: complex pathogenesis with partial dependence on hepcidin
Kim, A., Fung, E., Parikh, S. G., Valore, E. V., Gabayan, V., Nemeth, E., & Ganz, T. (2014) · Blood · doi:10.1182/blood-2013-08-521419 · Cited by 145 · see citing works
Self-citationHypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB
Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.-M., Kleinsasser, A., Burtscher, M., et al. (2014) · Gut · doi:10.1136/gutjnl-2013-305317 · Cited by 145 · see citing works
Hepcidin Mitigates Renal Ischemia-Reperfusion Injury by Modulating Systemic Iron Homeostasis
Scindia, Y., Dey, P., Thirunagari, A., Liping, H., Rosin, D. L., Floris, M., Okusa, M. D., & Swaminathan, S. (2015) · Journal of the American Society of Nephrology · doi:10.1681/asn.2014101037 · Cited by 141 · see citing works
Growth differentiation factor 15 in erythroid health and disease
Tanno, T., Noel, P., & Miller, J. L. (2010) · Current Opinion in Hematology · doi:10.1097/moh.0b013e328337b52f · Cited by 139 · see citing works
Low hepcidin accounts for the proinflammatory status associated with iron deficiency
Pagani, A., Nai, A., Corna, G., Bosurgi, L., Rovere-Querini, P., Camaschella, C., & Silvestri, L. (2011) · Blood · doi:10.1182/blood-2011-02-337212 · Cited by 138 · see citing works
Design of iron chelators with therapeutic application
Zhou, T., Ma, Y., Kong, X., & Hider, R. C. (2012) · Dalton Transactions · doi:10.1039/c2dt12159j · Cited by 136 · see citing works
Antibacterial Activities of Iron Chelators against Common Nosocomial Pathogens
Thompson, M. G., Corey, B. W., Si, Y., Craft, D. W., & Zurawski, D. V. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01197-12 · Cited by 135 · see citing works
Clark, M. A., Goheen, M. M., Fulford, A., Prentice, A. M., Elnagheeb, M. A., Patel, J., Fisher, N., Taylor, S. M., Kasthuri, R. S., & Cerami, C. (2014) · Nature Communications · doi:10.1038/ncomms5446 · Cited by 134 · see citing works
In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2
Maes, K., Nemeth, E., Roodman, G. D., Huston, A., Esteve, F., Freytes, C., Callander, N., Katodritou, E., Tussing-Humphreys, L., Rivera, S., et al. (2010) · Blood · doi:10.1182/blood-2010-03-274571 · Cited by 132 · see citing works
Self-citationHFE interacts with the BMP type I receptor ALK3 to regulate hepcidin expression
Wu, X.-G., Wang, Y., Wu, Q., Cheng, W. H., Liu, W., Zhao, Y., Mayeur, C., Schmidt, P. J., Yu, P. B., Wang, F., et al. (2014) · Blood · doi:10.1182/blood-2014-01-552281 · Cited by 129 · see citing works
Li, X., Yang, Y., Zhou, F., Zhang, Y., Lu, H., Jin, Q., & Gao, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015831 · Cited by 126 · see citing works
Gluconeogenic Signals Regulate Iron Homeostasis via Hepcidin in Mice
Vecchi, C., Montosi, G., Garuti, C., Corradini, E., Sabelli, M., Canali, S., & Pietrangelo, A. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.12.016 · Cited by 123 · see citing works
Dostal, A., Baumgartner, J., Riesen, N., Chassard, C., Smuts, C. M., Zimmermann, M. B., & Lacroix, C. (2014) · British Journal of Nutrition · doi:10.1017/s0007114514001160 · Cited by 121 · see citing works
Latour, C., Kautz, L., Besson-Fournier, C., Island, M.-L., Canonne-Hergaux, F., Loréal, O., Ganz, T., Coppin, H., & Roth, M.-P. (2014) · Hepatology · doi:10.1002/hep.26648 · Cited by 120 · see citing works
Self-citationKabyemela, E. R., Fried, M., Kurtis, J. D., Mutabingwa, T. K., & Duffy, P. E. (2008) · The Journal of Infectious Diseases · doi:10.1086/589512 · Cited by 116 · see citing works
Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts
Zhang, D.-L., Senecal, T., Ghosh, M. C., Ollivierre-Wilson, H., Tu, T., & Rouault, T. A. (2011) · Blood · doi:10.1182/blood-2011-01-330241 · Cited by 113 · see citing works
Inhibition of hepcidin transcription by growth factors
Goodnough, J. B., Ramos, E., Nemeth, E., & Ganz, T. (2012) · Hepatology · doi:10.1002/hep.25615 · Cited by 108 · see citing works
Self-citationGardenghi, S., Renaud, T. M., Meloni, A., Casu, C., Crielaard, B. J., Bystrom, L. M., Greenberg-Kushnir, N., Sasu, B. J., Cooke, K. S., & Rivella, S. (2014) · Blood · doi:10.1182/blood-2013-08-521625 · Cited by 107 · see citing works
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections
Armitage, A. E., Stacey, A. R., Giannoulatou, E., Marshall, E., Sturges, P., Chatha, K., Smith, N. M. G., Huang, X., Xu, X., Pasricha, S.-R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402351111 · Cited by 101 · see citing works
ER Stress-Inducible Factor CHOP Affects the Expression of Hepcidin by Modulating C/EBPalpha Activity
Oliveira, S. J., Pinto, J. P., Picarote, G., Costa, V. M., Carvalho, F. D., Rangel, M., de Sousa, M. A. B., & de Almeida, S. F. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006618 · Cited by 101 · see citing works
Bone Morphogenetic Proteins as Regulators of Iron Metabolism
Parrow, N. L., & Fleming, R. E. (2014) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071813-105646 · Cited by 99 · see citing works
The role of iron in infections with intracellular bacteria
Collins, H. L. (2003) · Immunology Letters · doi:10.1016/s0165-2478(02)00229-8 · Cited by 94 · see citing works
Elevated Iron Status Strongly Predicts Mortality in West African Adults With HIV Infection
McDermid, J. M., Jaye, A., van der Loeff, M. F. S., Todd, J., Bates, C. J., Austin, S. B., Jeffries, D. J., Awasana, A. A., Whittle, H. C., & Prentice, A. M. (2007) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31815b2d4b · Cited by 91 · see citing works
Olakanmi, O., Schlesinger, L. S., & Britigan, B. E. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0606405 · Cited by 88 · see citing works
Larson, J. A., Howie, H. L., & So, M. (2004) · Molecular Microbiology · doi:10.1111/j.1365-2958.2004.04169.x · Cited by 85 · see citing works
Severe bacterial infection in transfusion-dependent patients with thalassemia major
Wang, S.-C., Lin, K.-H., Chern, J. P. S., Lu, M.-Y., Jou, S.-T., Lin, D.-T., & Lin, K.-S. (2003) · Clinical Infectious Diseases · doi:10.1086/378062 · Cited by 80 · see citing works
Leishmania-Mediated Inhibition of Iron Export Promotes Parasite Replication in Macrophages
Ben-Othman, R., Flannery, A. R., Miguel, D. C., Ward, D. M., Kaplan, J., & Andrews, N. W. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1003901 · Cited by 76 · see citing works
Mayeur, C., Leyton, P. A., Kolodziej, S. A., Yu, B., & Bloch, K. D. (2014) · Blood · doi:10.1182/blood-2014-04-572644 · Cited by 74 · see citing works
IL-22 Regulates Iron Availability In Vivo through the Induction of Hepcidin
Smith, C. S., Arvedson, T., Cooke, K. S., Dickmann, L. J., Forte, C. P., Li, H., Merriam, K. L., Perry, V. K., Tran, L., Rottman, J. B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202716 · Cited by 72 · see citing works
Hepcidin is suppressed by erythropoiesis in hemoglobin E β-thalassemia and β-thalassemia trait
Jones, E., Pasricha, S.-R., Allen, A., Evans, P., Fisher, C. A., Wray, K., Premawardhena, A., Bandara, D., Perera, A., Webster, C., et al. (2015) · Blood · doi:10.1182/blood-2014-10-606491 · Cited by 68 · see citing works
Hemochromatosis and Vibrio vulnificus Wound Infections
Barton, J. C., & Acton, R. T. (2009) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31819069c1 · Cited by 67 · see citing works
Hereditary Hemochromatosis Restores the Virulence of Plague Vaccine Strains
Quenee, L. E., Hermanas, T. M., Ciletti, N., Louvel, H., Miller, N. C., Elli, D., Blaylock, B., Mitchell, A., Schroeder, J., Krausz, T., et al. (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis433 · Cited by 65 · see citing works
Maggio, A., Filosa, A., Vitrano, A., Aloj, G., Kattamis, A., Ceci, A., Fucharoen, S., Cianciulli, P., Grady, R. W., Prossomariti, L., et al. (2011) · Blood Cells, Molecules, and Diseases · doi:10.1016/j.bcmd.2011.07.002 · Cited by 65 · see citing works
Investigation of a Researcher's Death Due to Septicemic Plague
Frank, K. M., Schneewind, O., & Shieh, W.-J. (2011) · New England Journal of Medicine · doi:10.1056/nejmc1010939 · Cited by 62 · see citing works
Inherited disorders of iron metabolism
Camaschella, C., & Poggiali, E. (2011) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e3283425591 · Cited by 59 · see citing works
Vibrio vulnificus septicemia in a patient with the hemochromatosis HFE C282Y mutation
Gerhard, G. S., Levin, K. A., Goldstein, J. P., Wojnar, M. M., Chorney, M. J., & Belchis, D. A. (2001) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2001-125-1107-vvsiap · Cited by 58 · see citing works
Yersinia enterocolitica Infection with Multiple Liver Abscesses Uncovering a Primary Hemochromatosis
Höpfner, M., Nitsche, R., Rohr, A., Harms, D., Schubert, S., & Fölsch, U. R. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750066004 · Cited by 56 · see citing works
Bergmann, T. K., Vinding, K., & Hey, H. (2001) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655201750313450 · Cited by 51 · see citing works
Kim, S.-W., & Ponka, P. (2002) · Blood Cells Molecules and Diseases · doi:10.1006/bcmd.2002.0579 · Cited by 50 · see citing works
Iron overload in β-thalassemia intermedia: an emerging concern
Musallam, K. M., Cappellini, M. D., & Taher, A. T. (2013) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32835f5a5c · Cited by 50 · see citing works
Alcantara, J., Yu, R. H., & Schryvers, A. B. (1993) · Molecular Microbiology · doi:10.1111/j.1365-2958.1993.tb01658.x · Cited by 49 · see citing works
Ryan, J. D., Altamura, S., Devitt, E. J., Mullins, S., Lawless, M. W., Muckenthaler, M. U., & Crowe, J. (2012) · Hepatology · doi:10.1002/hep.25666 · Cited by 49 · see citing works
Hepcidin Activation During Inflammation: Make It STAT
Fleming, R. E. (2007) · Gastroenterology · doi:10.1053/j.gastro.2006.11.049 · Cited by 36 · see citing works
Survival Advantage of the Hemochromatosis C282Y Mutation
Weinberg, E. D. (2008) · Perspectives in biology and medicine · doi:10.1353/pbm.2008.0001 · Cited by 36 · see citing works
Salmonella enterica Infection Stimulates Macrophages to Hemophagocytose
Pilonieta, M. C., Moreland, S. M., English, C. N., & Detweiler, C. S. (2014) · mBio · doi:10.1128/mbio.02211-14 · Cited by 35 · see citing works
Identification and Characterisation of an Iron-Responsive Candidate Probiotic
Bailey, J. R., Probert, C. S. J., & Cogan, T. A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026507 · Cited by 25 · see citing works
Upregulation of iron regulatory hormone hepcidin by interferon α
Ichiki, K., Ikuta, K., Addo, L., Tanaka, H., Sasaki, Y., Shimonaka, Y., Sasaki, K., Ito, S., Shindo, M., Ohtake, T., et al. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12348 · Cited by 19 · see citing works
Horino, T., Matsumoto, T., Uramatsu, M., Tanabe, M., Tateda, K., Miyazaki, S., Nakane, A., Iwakura, Y., & Yamaguchi, K. (2005) · Cytokine · doi:10.1016/j.cyto.2005.01.002 · Cited by 13 · see citing works
In vivo role(s) of the iron regulatory proteins (IRP) 1 and 2 in aseptic local inflammation
Viatte, L., Gröne, H.-J., Hentze, M. W., & Galy, B. (2009) · Journal of Molecular Medicine · doi:10.1007/s00109-009-0494-8 · Cited by 11 · see citing works
Flagged first, then by citations
4 of the 100 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319 · see citing works
Towards the sustainable discovery and development of new antibiotics
Miethke, M., Pieroni, M., Weber, T., Brönstrup, M., Hammann, P., Halby, L., Arimondo, P. B., Glaser, P., Aigle, B., Bode, H. B., et al. (2021) · Nature Reviews Chemistry · doi:10.1038/s41570-021-00313-1 · Cited by 1,184 · see citing works
Weiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219 · see citing works
Self-citationBiomarkers of Nutrition for Development—Folate Review
Bailey, L. B., Stover, P. J., McNulty, H., Fenech, M. F., Gregory, J. F., Mills, J. L., Pfeiffer, C. M., Fazili, Z., Zhang, M., Ueland, P. M., et al. (2015) · Journal of Nutrition · doi:10.3945/jn.114.206599 · Cited by 1,147 · see citing works
Metabolic coordination of T cell quiescence and activation
Chapman, N. M., Boothby, M. R., & Chi, H. (2019) · Nature reviews. Immunology · doi:10.1038/s41577-019-0203-y · Cited by 749 · see citing works
Iron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724 · see citing works
Current understanding of iron homeostasis
Anderson, G. J., & Frazer, D. M. (2017) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.117.155804 · Cited by 688 · see citing works
Nutrition, immunity and COVID-19
Calder, P. C. (2020) · BMJ Nutrition Prevention & Health · doi:10.1136/bmjnph-2020-000085 · Cited by 587 · see citing works
Iron and cancer: recent insights
Manz, D. H., Blanchette, N. L., Paul, B. T., Torti, F. M., & Torti, S. V. (2016) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13008 · Cited by 507 · see citing works
Overview of iron metabolism in health and disease
Dev, S., & Babitt, J. L. (2017) · Hemodialysis International · doi:10.1111/hdi.12542 · Cited by 469 · see citing works
Ligthart, S., Vaez, A., Võsa, U., Stathopoulou, M. G., de Vries, P. S., Prins, B. P., van der Most, P. J., Tanaka, T., Naderi, E., Rose, L. M., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.09.009 · Cited by 416 · see citing works
Masaldan, S., Clatworthy, S. A. S., Gamell, C., Meggyesy, P. M., Rigopoulos, A.-T., Haupt, S., Haupt, Y., Denoyer, D., Adlard, P. A., Bush, A. I., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2017.08.015 · Cited by 452 · see citing works
Oral Microbiome Composition Reflects Prospective Risk for Esophageal Cancers
Peters, B. A., Wu, J., Pei, Z., Yang, L., Purdue, M. P., Freedman, N. D., Jacobs, E. J., Gapstur, S. M., Hayes, R. B., & Ahn, J. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1296 · Cited by 423 · see citing works
Hepcidin in the diagnosis of iron disorders
Girelli, D., Nemeth, E., & Swinkels, D. W. (2016) · Blood · doi:10.1182/blood-2015-12-639112 · Cited by 417 · see citing works
Self-citationMacrophages and Iron Metabolism
Soares, M. P., & Hamza, I. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.016 · Cited by 401 · see citing works
Bertrand, R. L. (2019) · Journal of Bacteriology · doi:10.1128/jb.00697-18 · Cited by 361 · see citing works
Iron in infection and immunity
Nairz, M., & Weiss, G. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100864 · Cited by 359 · see citing works
Iron Homeostasis in Health and Disease
Gozzelino, R., & Arosio, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010130 · Cited by 370 · see citing works
Targeting iron metabolism in drug discovery and delivery
Crielaard, B. J., Lammers, T., & Rivella, S. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.248 · Cited by 352 · see citing works
Biomarkers of Nutrition for Development (BOND)—Iron Review
Lynch, S. R., Pfeiffer, C. M., Georgieff, M., Brittenham, G. M., Fairweather‐Tait, S. J., Hurrell, R. F., McArdle, H. J., & Raiten, D. J. (2018) · Journal of Nutrition · doi:10.1093/jn/nxx036 · Cited by 348 · see citing works
The Role of Minerals in the Optimal Functioning of the Immune System
Weyh, C., Krüger, K., Peeling, P., & Castell, L. M. (2022) · Nutrients · doi:10.3390/nu14030644 · Cited by 349 · see citing works
Ceruloplasmin and other copper binding components of blood plasma and their functions: an update
Linder, M. C. (2016) · Metallomics · doi:10.1039/c6mt00103c · Cited by 308 · see citing works
NUPR1 is a critical repressor of ferroptosis
Liu, J., Song, X., Kuang, F., Zhang, Q., Xie, Y., Kang, R., Kroemer, G., & Tang, D. (2021) · Nature Communications · doi:10.1038/s41467-021-20904-2 · Cited by 290 · see citing works
Wang, Y., Lei, Y., Ding, J. P., & Chen, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010095 · Cited by 297 · see citing works
Bacterial Siderophores: Classification, Biosynthesis, Perspectives of Use in Agriculture
Timofeeva, A. M., Galyamova, M. R., & Sedykh, S. E. (2022) · Plants · doi:10.3390/plants11223065 · Cited by 324 · see citing works
Iron metabolism: pathophysiology and pharmacology
Roemhild, K., von Maltzahn, F., Weiskirchen, R., Knüchel, R., von Stillfried, S. F., & Lammers, T. (2021) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.05.001 · Cited by 315 · see citing works
The Role of Iron Regulation in Immunometabolism and Immune-Related Disease
Cronin, S. J. F., Woolf, C. J., Weiss, G., & Penninger, J. M. (2019) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2019.00116 · Cited by 299 · see citing works
Metalloimmunology: The metal ion-controlled immunity
Wang, C., Zhang, R., Wei, X., Lv, M., & Jiang, Z. (2019) · Advances in immunology · doi:10.1016/bs.ai.2019.11.007 · Cited by 300 · see citing works
Timofeeva, A. M., Galyamova, M. R., & Sedykh, S. E. (2023) · Plants · doi:10.3390/plants12244074 · Cited by 336 · see citing works
Iron Metabolism and Immune Regulation
Ni, S., Yuan, Y., Kuang, Y., & Li, X. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.816282 · Cited by 266 · see citing works
Gerwien, F., Skrahina, V., Kasper, L., Hube, B., & Brunke, S. (2017) · FEMS Microbiology Reviews · doi:10.1093/femsre/fux050 · Cited by 246 · see citing works
Li, C., Sun, G., Chen, B., Xu, L., Ye, Y., He, J., Bao, Z., Zhao, P., Miao, Z., Zhao, L., et al. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105933 · Cited by 258 · see citing works
Hepcidin regulation in the anemia of inflammation
Wang, C., & Babitt, J. L. (2016) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000236 · Cited by 256 · see citing works
The Role of Iron and Siderophores in Infection, and the Development of Siderophore Antibiotics
Page, M. G. P. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz825 · Cited by 250 · see citing works
Bellmann-Weiler, R., Lanser, L., Barket, R., Rangger, L., Schapfl, A., Schaber, M., Fritsche, G., Wöll, E., & Weiss, G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082429 · Cited by 244 · see citing works
Mechanisms of red blood cell transfusion‐related immunomodulation
Remy, K. E., Hall, M. W., Cholette, J. M., Juffermans, N. P., Nicol, K. K., Doctor, A., Blumberg, N., Spinella, P. C., Norris, P. J., Dahmer, M. K., et al. (2018) · Transfusion · doi:10.1111/trf.14488 · Cited by 248 · see citing works
Verbon, E. H., Trapet, P. L., Stringlis, I. A., Kruijs, S., Bakker, P. A. H. M., & Pieterse, C. M. J. (2017) · Annual Review of Phytopathology · doi:10.1146/annurev-phyto-080516-035537 · Cited by 241 · see citing works
Tang, B., Zhu, J., Li, J., Fan, K. C., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., et al. (2020) · Cell Communication and Signaling · doi:10.1186/s12964-020-00663-1 · Cited by 217 · see citing works
Basics and principles of cellular and systemic iron homeostasis
Katsarou, A., & Pantopoulos, K. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2020.100866 · Cited by 220 · see citing works
Madeddu, C., Gramignano, G., Astara, G., Demontis, R., Sanna, E., Atzeni, V., & Macciò, A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01294 · Cited by 209 · see citing works
Coordinatively Unsaturated Fe 3+ Based Activatable Probes for Enhanced MRI and Therapy of Tumors
Zhang, P., Hou, Y., Zeng, J., Li, Y., Wang, Z., Zhu, R., Ma, T., & Gao, M. (2019) · Angewandte Chemie International Edition · doi:10.1002/anie.201904880 · Cited by 191 · see citing works
Targeting ferroptosis protects against experimental (multi)organ dysfunction and death
Van Coillie, S., Van San, E., Goetschalckx, I., Wiernicki, B., Mukhopadhyay, B., Tonnus, W., Choi, S. M., Roelandt, R., Dumitrascu, C., Lamberts, L., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28718-6 · Cited by 186 · see citing works
Regulation of tissue iron homeostasis: the macrophage “ferrostat”
Winn, N. C., Volk, K. M., & Hasty, A. H. (2020) · JCI Insight · doi:10.1172/jci.insight.132964 · Cited by 177 · see citing works
“Pumping iron”—how macrophages handle iron at the systemic, microenvironmental, and cellular levels
Nairz, M., Theurl, I., Swirski, F. K., & Weiss, G. (2017) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-017-1944-8 · Cited by 178 · see citing works
The Iron Tug-of-War between Bacterial Siderophores and Innate Immunity
Golonka, R. M., Yeoh, B. S., & Vijay–Kumar, M. (2019) · Journal of Innate Immunity · doi:10.1159/000494627 · Cited by 173 · see citing works
Ferroptotic stress promotes macrophages against intracellular bacteria
Ma, R., Fang, L., Chen, L., Wang, X., Jiang, J., & Gao, L. (2022) · Theranostics · doi:10.7150/thno.66663 · Cited by 167 · see citing works
Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
Busti, F., Marchi, G., Ugolini, S., Castagna, A., & Girelli, D. (2018) · Pharmaceuticals · doi:10.3390/ph11040094 · Cited by 166 · see citing works
Papier, K., Fensom, G. K., Knuppel, A., Appleby, P. N., Tong, T. Y. N., Schmidt, J. A., Travis, R. C., Key, T. J., & Perez-Cornago, A. (2021) · BMC Medicine · doi:10.1186/s12916-021-01922-9 · Cited by 168 · see citing works
Morris, G., Berk, M., Carvalho, A. F., Maes, M. H. J., Walker, A. J., & Puri, B. K. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.12.036 · Cited by 154 · see citing works
Nairz, M., Theurl, I., Wolf, D., & Weiss, G. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0505-7 · Cited by 152 · see citing works
Iron Deficiency in Heart Failure: Mechanisms and Pathophysiology
Alnuwaysir, R. I. S., Hoes, M. F., van Veldhuisen, D. J., van der Meer, P., & Beverborg, N. G. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm11010125 · Cited by 170 · see citing works
Lanser, L., Fuchs, D., Kurz, K., & Weiß, G. (2021) · Nutrients · doi:10.3390/nu13113732 · Cited by 166 · see citing works
Iron Homeostasis Disorder and Alzheimer’s Disease
Peng, Y., Chang, X., & Lang, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212442 · Cited by 143 · see citing works
The Role of Nutrition in COVID-19 Susceptibility and Severity of Disease: A Systematic Review
James, P. T., Ali, Z., Armitage, A. E., Bonell, A., Cerami, C., Drakesmith, H., Jobe, M., Jones, K. S., Liew, Z., Moore, S. E., et al. (2021) · The Journal of Nutrition · doi:10.1093/jn/nxab059 · Cited by 147 · see citing works
Moll, R., & Davis, B. (2017) · Medicine · doi:10.1016/j.mpmed.2017.01.007 · Cited by 144 · see citing works
Ayon, N. J. (2023) · Metabolites · doi:10.3390/metabo13050625 · Cited by 156 · see citing works
Pharmacological Targeting of the Hepcidin/Ferroportin Axis
Sebastiani, G., Wilkinson, N., & Pantopoulos, K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00160 · Cited by 127 · see citing works
Ironing out mechanisms of iron homeostasis and disorders of iron deficiency
Koleini, N., Shapiro, J. S., Geier, J., & Ardehali, H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci148671 · Cited by 145 · see citing works
IL-22 controls iron-dependent nutritional immunity against systemic bacterial infections
Sakamoto, K., Kim, Y.-G., Hara, H., Kamada, N., Caballero-Flores, G., Tolosano, E., Soares, M. P., Puente, J. L., Inohara, N., & Núñez, G. (2017) · Science Immunology · doi:10.1126/sciimmunol.aai8371 · Cited by 127 · see citing works
Cholera toxin promotes pathogen acquisition of host-derived nutrients
Rivera-Chávez, F., & Mekalanos, J. J. (2019) · Nature · doi:10.1038/s41586-019-1453-3 · Cited by 124 · see citing works
Hepcidin agonists as therapeutic tools
Casu, C., Nemeth, E., & Rivella, S. (2018) · Blood · doi:10.1182/blood-2017-11-737411 · Cited by 131 · see citing works
Self-citationZhu, W., Miyata, N., Winter, M. G., Arenales, A., Hughes, E. R., Spiga, L., Kim, J., Sifuentes-Dominguez, L., Starokadomskyy, P., Gopal, P., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20181939 · Cited by 124 · see citing works
Role of divalent metals in infectious disease susceptibility and outcome
Weiss, G., & Carver, P. L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.018 · Cited by 123 · see citing works
Iron Reduces M1 Macrophage Polarization in RAW264.7 Macrophages Associated with Inhibition of STAT1
Gan, Z.-S., Wang, Q., Li, J., Wang, X., Wang, Y., & Du, H. (2017) · Mediators of Inflammation · doi:10.1155/2017/8570818 · Cited by 127 · see citing works
Macías‐Rodríguez, R. U., Inzaugarat, M. E., Ruiz‐Margáin, A., Nelson, L. J., Trautwein, C., & Cubero, F. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051651 · Cited by 114 · see citing works
Systemic iron homeostasis and erythropoiesis
Papanikolaou, G. V., & Pantopoulos, K. (2017) · IUBMB Life · doi:10.1002/iub.1629 · Cited by 122 · see citing works
Iron and innate antimicrobial immunity-depriving the pathogen, defending the host
Nairz, M., Dichtl, S., Schroll, A., Haschka, D., Tymoszuk, P., Theurl, I., & Weiss, G. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.03.007 · Cited by 123 · see citing works
Iron at the Centre of Candida albicans Interactions
Fourie, R., Kuloyo, O. O., Mochochoko, B. M., Albertyn, J., & Pohl, C. H. (2018) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2018.00185 · Cited by 118 · see citing works
Núñez, G., Sakamoto, K., & Soares, M. P. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1800325 · Cited by 115 · see citing works
Kell, D. B., & Pretorius, E. (2018) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12407 · Cited by 113 · see citing works
Zhang, D.-C., Gao, X., Li, H., Borger, D. K., Wei, Q.-Z., Yang, E., Xu, C.-L., Pinho, S., & Frenette, P. (2022) · Cell Stem Cell · doi:10.1016/j.stem.2021.12.009 · Cited by 95 · see citing works
Nanoparticle Effects on Stress Response Pathways and Nanoparticle–Protein Interactions
Cameron, S. J., Sheng, J., Hosseinian, F. S., & Willmore, W. G. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23147962 · Cited by 126 · see citing works
Iron Regulation of Pancreatic Beta-Cell Functions and Oxidative Stress
Backe, M. B., Moen, I. W., Ellervik, C., Hansen, J. B., & Mandrup-Poulsen, T. R. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050939 · Cited by 116 · see citing works
Katsarou, A., & Pantopoulos, K. (2018) · Pharmaceuticals · doi:10.3390/ph11040127 · Cited by 115 · see citing works
Jiang, Y., Jiang, F., Kong, F., An, M.-M., Jin, B.-B., Cao, D., & Gong, P. (2019) · Annals of Intensive Care · doi:10.1186/s13613-019-0542-7 · Cited by 118 · see citing works
The role of hepcidin and iron homeostasis in atherosclerosis
Wunderer, F., Traeger, L., Sigurslid, H. H., Meybohm, P., Bloch, D. B., & Malhotra, R. K. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104664 · Cited by 107 · see citing works
The “Iron”-y of Iron Overload and Iron Deficiency in Chronic Obstructive Pulmonary Disease
Cloonan, S. M., Mumby, S. E., Adcock, I. M., Choi, A. M. K., Chung, K. F., & Quinlan, G. J. (2017) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201702-0311pp · Cited by 109 · see citing works
Role of the Gram-Negative Envelope Stress Response in the Presence of Antimicrobial Agents
Guest, R. L., & Raivio, T. L. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.001 · Cited by 102 · see citing works
Iron homeostasis and disorders revisited in the sepsis
Liu, Q., Wu, J., Zhang, X., Wu, X., Zhao, Y., & Ren, J. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.01.025 · Cited by 112 · see citing works
Iron, glucose and fat metabolism and obesity: an intertwined relationship
Hilton, C., Sabaratnam, R., Drakesmith, H., & Karpe, F. (2023) · International Journal of Obesity · doi:10.1038/s41366-023-01299-0 · Cited by 113 · see citing works
Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma
Ali, M. K., Kim, R., Brown, A. C., Mayall, J., Karim, R., Pinkerton, J., Liu, G., Martin, K. L., Starkey, M. R., Pillar, A. L., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01340-2019 · Cited by 98 · see citing works
Cutone, A., Rosa, L., Lepanto, M. S., Scotti, M. J., Berlutti, F., di Patti, M. C. B., Musci, G., & Valenti, P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00705 · Cited by 99 · see citing works
Inherited Disorders of Iron Overload
Pantopoulos, K. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00103 · Cited by 98 · see citing works
Biology of Anemia: A Public Health Perspective
Brittenham, G. M., Moir-Meyer, G., Abuga, K. M., Datta-Mitra, A., Cerami, C., Green, R., Pasricha, S., & Atkinson, S. H. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.07.018 · Cited by 122 · see citing works
Acute kidney injury and distant organ dysfunction–network system analysis
Matsuura, R., Doi, K., & Rabb, H. (2023) · Kidney International · doi:10.1016/j.kint.2023.03.025 · Cited by 100 · see citing works
Sangal, V., & Hoskisson, P. A. (2016) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2016.06.024 · Cited by 96 · see citing works
Receptor-Mediated Drug Delivery Systems Targeting to Glioma
Wang, S., Meng, Y., Li, C., Qian, M., & Huang, R. (2015) · Nanomaterials · doi:10.3390/nano6010003 · Cited by 95 · see citing works
The interaction of nutrient uptake with biotic and abiotic stresses in plants
Wang, L., Ju, C., Han, C., Yu, Z., Bai, M., & Wang, C. (2025) · Journal of Integrative Plant Biology · doi:10.1111/jipb.13827 · Cited by 100 · see citing works
Ferroptosis in viral infection: the unexplored possibility
Wang, M., Banda, J., Jin, N., Du, S., & Li, C. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-021-00814-1 · Cited by 90 · see citing works
Berretta, M., Quagliariello, V., Maurea, N., Francia, R. D., Sharifi, S., Facchini, G., Rinaldi, L., Piezzo, M., Manuela, C., Nunnari, G., et al. (2020) · Antioxidants · doi:10.3390/antiox9121182 · Cited by 91 · see citing works
Iron metabolism and iron deficiency anemia in women
Cappellini, M. D., Santini, V., Braxs, C., & Shander, A. (2022) · Fertility and Sterility · doi:10.1016/j.fertnstert.2022.08.014 · Cited by 101 · see citing works
Cena, H., Fiechtner, L. G., Vincenti, A., Magenes, V. C., Giuseppe, R. D., Manuelli, M. C., Zuccotti, G., & Calcaterra, V. (2021) · Nutrients · doi:10.3390/nu13124255 · Cited by 90 · see citing works
Novel reprogramming of neutrophils modulates inflammation resolution during atherosclerosis
Geng, S., Zhang, Y., Lee, C., & Li, L. (2019) · Science Advances · doi:10.1126/sciadv.aav2309 · Cited by 80 · see citing works
Iron status in the elderly: A review of recent evidence
Wawer, A. A., Jennings, A., & Fairweather‐Tait, S. J. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.003 · Cited by 76 · see citing works
Food-Associated Stress Primes Foodborne Pathogens for the Gastrointestinal Phase of Infection
Horn, N. L., & Bhunia, A. K. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01962 · Cited by 81 · see citing works
Staphylococcus aureus heme and siderophore-iron acquisition pathways
Conroy, B. S., Grigg, J. C., Kolesnikov, M., Morales, L. D., & Murphy, M. E. P. (2019) · BioMetals · doi:10.1007/s10534-019-00188-2 · Cited by 73 · see citing works
Iron overload induces colitis by modulating ferroptosis and interfering gut microbiota in mice
Gu, K., Wu, A., Yu, B., Zhang, T., Lai, X., Chen, J., Yan, H., Zheng, P., Luo, Y., Luo, J., et al. (2023) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2023.167043 · Cited by 79 · see citing works
Flipside of the Coin: Iron Deficiency and Colorectal Cancer
Aksan, A., Farrag, K., Aksan, S., Schroeder, O., & Stein, J. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.635899 · Cited by 74 · see citing works
Anaemia, iron status, and gender predict the outcome in patients with chronic heart failure
Kurz*†, K., Lanser†, L., Seifert, M., Kocher, F., Pölzl, G., & Weiss*, G. (2020) · ESC Heart Failure · doi:10.1002/ehf2.12755 · Cited by 77 · see citing works
Iron metabolism in infections: Focus on COVID-19
Girelli, D., Marchi, G., Busti, F., & Vianello, A. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.07.001 · Cited by 74 · see citing works
- Authors
- Ganz, T., & Nemeth, E.
- Affiliations
- University of California, Los Angeles (US)
- University of California System (US)
- Corresponding author
- Ganz, Tomas
- Venue
- Nature Reviews Immunology
- Published
- 2015-07-10
- Volume
- 15
- Issue
- 8
- Pages
- 500-510
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- PMC
- PMC4801113
- OpenAlex
- W1570067866
- Cited by
- 843
- References
- 100
- Citations by year
- 2026: 89 · 2025: 78 · 2024: 90 · 2023: 75 · 2022: 103 · 2021: 81 · 2020: 82 · 2019: 63 · 2018: 69 · 2017: 58 · 2016: 47 · 2015: 7
- FWCI
- 9.02
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- CYTED Ciencia y Tecnología para el Desarrollo
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK107309)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Ferroptosis and cancer prognosis
- Health Sciences › Nursing › Nutrition and Dietetics › Trace Elements in Health
- Keywords
- iron homeostasis, nutritional immunity, host defense, inflammation, iron limitation, infection, macrophages, cytokine production
- MeSH terms
- Animals, Bacterial Infections, Gene Expression Regulation, Homeostasis, Humans, Immunity, Innate, Inflammation, Iron, Macrophages, Signal Transduction, Cytokines, Nonheme Iron Proteins, Iron-Binding Proteins, Iron-Regulatory Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-05.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-05.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review